Takeda Pharmaceutical
The Latest
-
Japan To Purchase 150 Million Doses Of Locally Produced COVID-19 Vaccine
Takeda will be producing 150 million doses of its own version of Novavax's vaccine, called TAK-019, for Japan's vaccination campaign. 
Takeda will be producing 150 million doses of its own version of Novavax's vaccine, called TAK-019, for Japan's vaccination campaign. -
Takeda Pharmaceutical Commits To China Expansion
Takeda Pharmaceutical has spent more than 1.5 billion yuan over the past five years to build its business in China. 
Takeda Pharmaceutical has spent more than 1.5 billion yuan over the past five years to build its business in China.
